1. PFE:NYQ

    Pfizer Inc

    USD

    28.30

    Today's change

    0.02 / +0.07%

    1 year change

    -7.76%

    As of Oct 22 2014 21:00 BST. Data delayed by at least 15 minutes.

Search for Pfizer Inc and
  1. October 21, 2014

    Technology, tax and talent in Dublin

    Dozens of giant light-sticks illuminate the path to Dublin’s Grand Canal Theatre at night, glowing red and flashing in...

  2. October 17, 2014

    Pfizer’s AstraZeneca pursuit knocked by Shire deal collapse

    The chances of Pfizer reviving its pursuit of AstraZeneca have been greatly diminished after the collapse of AbbVie’s £32bn...

Special Reports

  1. Combating Cancer

    A wave of drugs that harnesses the body’s immune system is fuelling optimism that scie...
  2. Combating Neglected Diseases

    While nobody questions the horror of the Ebola epidemic sweeping west Africa, the deat...
Search more Special Reports on this topic.

  1. October 16, 2014

    Pharma giants face developing market ambitions

    As the pharmaceuticals industry careered towards the edge of its notorious patent cliff over the past decade, there was one...

  2. October 13, 2014

    Renewed merger hopes boost AstraZeneca

    Refreshed hopes of another approach from Pfizer put AstraZeneca back in demand on Monday. AstraZeneca has slipped over the...

  3. October 9, 2014

    Environmental and educational efforts lead assault on trachoma

    Some diseases are devastating because of their symptoms, some because of their outcome. Blinding trachoma is both:...

  4. September 28, 2014

    Drugs groups trapped in tangled M&A web

    When Valeant offered almost $46bn to buy Allergan in April, it seemed like a large but relatively straightforward deal....

  5. September 26, 2014

    Battling cancer: Focus turns to defence as best form of attack

    It has been described as the beginning of the end of cancer. A new wave of drugs that harnesses the body’s immune system to...

  6. September 26, 2014

    Drug development: Big pharma back in the game it made

    Big pharma is back. That, at least, is the impression created by a wave of new cancer drugs rapidly approaching market....

  7. September 23, 2014

    Curbs on tax inversions fail to convince

    Dissections of a White House plan to curb tax-driven mergers gave way on Tuesday to a realisation that the most significant...

  8. September 23, 2014

    CarMax sputters on disappointing sales

    Shares of CarMax, the largest US used auto dealer, declined on Tuesday after same-store sales nearly flatlined and earnings...

  9. September 23, 2014

    US Treasury hopes to stand logic of tax inversion deals on head

    Taxes may be one of the only two certainties, but tax benefits are very uncertain – as the US Treasury has just...

  10. September 23, 2014

    London stocks hit by US tax crackdown

    London’s equity markets were lower for a second session this week, with drugmakers leading losses after US authorities...

  11. September 15, 2014

    Takeover Panel proposes tougher rules for deal promises

    The body that polices UK dealmaking has proposed strengthening its governing Takeover Code to address promises made during...

  12. September 11, 2014

    Pfizer says ‘window still open’ for tax inversions

    Pfizer says the window is still open for US companies to use transatlantic deals to lower their tax rates despite President...

  13. August 29, 2014

    AstraZeneca gains on renewed bid chatter

    AstraZeneca was among the FTSE 100 leaders on Friday as bid chatter continued to prod the drug company’s shares higher. The...

  14. August 28, 2014

    Douglas Carswell in quotes

    Tory MP Douglas Carswell, who defected to the anti-Brussels, anti-immigration UK Independence party on Thursday, is a...

  15. August 24, 2014

    Pfizer weighs options on AstraZeneca bid

    Pfizer is considering its acquisition options as a potential path opens this week for the US drugmaker to renew its pursuit...

  16. August 21, 2014

    Drugmaker link-up puts Astra on top

    The UK’s two biggest drugmakers both made it on to the FTSE 100 leaderboard after AstraZeneca developed a partnership that...

  17. August 6, 2014

    Pharma shares slide on fears of ‘tax inversion’ clampdown

    Investors fled global healthcare stocks on Wednesday after the Obama administration threatened action to halt the wave of...

  18. August 4, 2014

    AstraZeneca chairman Leif Johansson defends Pfizer rebuff

    Leif Johansson wants to set something straight: he does not want to be prime minister of Sweden. This was just one of the...

  19. August 1, 2014

    GlaxoSmithKline vulnerable to Pfizer bid after price slump

    GlaxoSmithKline’s fall to an 18-month low might make the drugmaker vulnerable, according to Berenberg analysts. A 20 per...

  20. July 31, 2014

    AstraZeneca raises full-year earnings guidance

    AstraZeneca raised its full-year earnings guidance on Thursday as Pascal Soriot, chief executive, declared “significant...

  21. July 30, 2014

    AstraZeneca to bolster respiratory drugs with Almirall deal

    AstraZeneca has bought a range of respiratory drugs from Almirall of Spain for up to $2.1bn in its biggest deal since...

  22. FT Alphaville

    July 29, 2014

    The Closer

    FURTHER FURTHER READING - FT editorial on Russia and sanctions. - Math + statistics = great beach reading. - Why the...

  23. July 29, 2014

    Pfizer refuses to rule out tax inversion deals

    Pfizer has called for “fundamental reform” of the US tax system – but said it was still interested in acquisitions that...

  24. July 18, 2014

    Technology: Wear your medicine

    Walter de Brouwer’s life changed when his son fell 35 feet from a window. Spending anxious months in intensive care, the...

  25. July 14, 2014

    AbbVie closes in on £31bn takeover of Shire

    AbbVie is closing in on a £31bn takeover of Shire in what would be the latest example of a US company buying a European...

  26. July 13, 2014

    Vince Cable plans to toughen up takeover rules

    Vince Cable plans to strengthen Britain’s takeover rules to make it harder for international bidders to renege on promises...

  27. July 8, 2014

    Cable backtracks on move to protect science industry

    Vince Cable has signalled the coalition will resist the Labour party’s demands for stronger government powers to intervene...

  28. July 8, 2014

    AbbVie avoids Pfizer errors in bear hug against Shire

    My pals are bigger than your pals. AbbVie has resorted to an old playground intimidation tactic, by implying a majority of...

  29. July 6, 2014

    Science parks’ role as innovation centres ‘under threat’

    The chairman of the UK Science Park Association has warned that their role as centres for business innovation is under...

  30. July 1, 2014

    AstraZeneca chief increases stake in drugmaker

    AstraZeneca’s chief executive has signalled his confidence in the company’s prospects by buying £2m worth of its shares,...

  31. June 29, 2014

    Green chemistry: Pharmaceutical companies try to clean up their act

    Pharmaceutical companies tend to highlight their role in saving lives, but say little about the impact their manufacturing...

  32. Business Blog

    June 27, 2014

    Defensive play in the World Cup of corporate taxation

    The global system for taxing multinational companies is broken, but no country wants to alter it too radically for fear of...

  33. June 20, 2014

    AstraZeneca set to bolster takeover defences

    AstraZeneca is considering selling the rights to some of its future revenues in a move that would boost the UK drugmaker’s...

  34. June 17, 2014

    Major pharmaceutical groups may be too big to succeed

    As Pfizer eyed a £70bn takeover of AstraZeneca this spring, the prospective deal highlighted an awkward truth for the chief...

  35. June 16, 2014

    Medtronic / Covidien: tax and save

    The news release did not mention tax benefits. The fact that the combined company would be Irish came two-thirds of the way...

  36. June 12, 2014

    Taxing time ahead as offshore rules come under more scrutiny

    ‘Golden age’ for offshore cash The OECD called it “the golden age” of tax planning: a period in which multinational...

  37. June 11, 2014

    A new approach is needed for British dealmaking

    Many countries have liberalised their takeover regimes in the past three decades. Thanks to this and the impact of...

  38. June 8, 2014

    Hostile takeovers rise to 14-year high in M&A as confidence grows

    Hostile takeover offers are making up the greatest proportion of global deal activity in 14 years as resurgent economic...

Search for Pfizer Inc and

RELATED VIDEOS

Videos from FT.com that closely match this topic

  1. Lex on the rejection of Pfizer's ‘final’ bid...
    May 19, 2014

    Lex on the rejection of Pfizer's ‘final’ bid

  2. The FT debates Pfizer's takeover bid for AstraZeneca...
    May 13, 2014

    The FT debates Pfizer's takeover bid for AstraZeneca